back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-19 14:12 Tx date 2025-03-18 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+1,937 vol |
5,225 | |
| Filed 2025-03-11 13:36 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$143.64
+12 vol $11.97 each |
3,288 | |
| Filed 2025-03-11 13:30 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,173
+121 vol $9.70 each |
3,276 | |
| Filed 2024-11-28 10:08 Tx date 2024-11-26 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,088
+555 vol $10.97 each |
3,155 | |
| Filed 2024-11-28 10:05 Tx date 2024-11-26 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-6,088.35
-555 vol $10.97 each |
3,610 | |
| Filed 2024-03-28 10:03 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+1,193 vol |
2,600 | |
| Filed 2018-06-27 Tx date 2018-06-25 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$18,035
+4,053 vol $4.45 each |
4,053 | |
| Filed 2018-06-27 Tx date 2018-06-25 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,261
+1,407 vol $4.45 each |
||
| Filed 2018-06-27 Tx date 2018-06-25 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,137
-2,646 vol $9.50 each |
1,407 | |
| Filed 2018-06-26 Tx date 2018-06-25 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-18,035.85
-4,053 vol $4.45 each |
4,165 | |
| Filed 2018-06-26 Tx date 2018-06-25 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,261
+1,407 vol $4.45 each |
1,407 | |
| Filed 2018-06-26 Tx date 2014-01-15 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-09 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$10,905
+1,136 vol $9.60 each |
8,218 | |
| Filed 2017-03-15 Tx date 2017-03-15 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$9,158
+1,246 vol $7.35 each |
7,082 | |
| Filed 2016-02-16 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$7,613
+1,228 vol $6.20 each |
5,836 |